第Ⅱ因子阻害剤のパイプライン・インサイト2018

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIMR2016267)
◆英語タイトル:Factor II (Prothrombin) Inhibitors -Pipeline Insights, 2018
◆発行会社/調査会社:DelveInsight
◆商品コード:DIMR2016267
◆発行日:2019年05月
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥137,500見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[第Ⅱ因子阻害剤のパイプライン・インサイト2018]についてメールでお問い合わせはこちら
本調査レポートでは、世界における第Ⅱ因子阻害剤のパイプライン動向について調査・分析し、以下の構成でお届けいたします。

・第Ⅱ因子阻害剤の概要
・第Ⅱ因子阻害剤のパイプライン概要
・企業別開発中の第Ⅱ因子阻害剤
・後期治験段階の薬剤(Filed & Phase III):比較分析
・中期治験段階の薬剤(Phase II):比較分析
・初期治験段階の薬剤(Phase I & IND Filed):比較分析
・薬剤候補のプロファイル
・第Ⅱ因子阻害剤の評価
  - 単剤治療薬別評価
  - 併用治療薬別評価
  - 投与経路別評価
  - 分子種類別評価
・開発が中止された薬剤リスト
・開発休止中の薬剤リスト
・第Ⅱ因子阻害剤開発に取り組んでいる企業リスト
・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s, “Factor II (Prothrombin) Inhibitors-Pipeline Insights, 2018”, report provides in depth insights on the pipeline drugs and their development activities around the Factor II (Prothrombin) Inhibitors. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Factor II (Prothrombin) Inhibitors. DelveInsight’s Report also assesses the Factor II (Prothrombin) Inhibitors therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.


Scope
• The report provides competitive pipeline landscape of Factor II (Prothrombin) Inhibitors
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Factor II (Prothrombin) Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Factor II (Prothrombin) Inhibitors and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


*** レポート目次(コンテンツ)***

Table of Contents
• Factor II (Prothrombin) Inhibitors Overview
• Factor II (Prothrombin) Inhibitors Disease Associated
• Factor II (Prothrombin) Inhibitors Pipeline Therapeutics
• Factor II (Prothrombin) Inhibitors Therapeutics under Development by Companies
• Factor II (Prothrombin) Inhibitors Filed and Phase III Products
• Comparative Analysis
• Factor II (Prothrombin) Inhibitors Phase II Products
• Comparative Analysis
• Factor II (Prothrombin) Inhibitors Phase I and IND Filed Products
• Comparative Analysis
• Factor II (Prothrombin) Inhibitors Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Factor II (Prothrombin) Inhibitors – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Factor II (Prothrombin) Inhibitors – Discontinued Products
• Factor II (Prothrombin) Inhibitors – Dormant Products
• Companies Involved in Therapeutics Development for Factor II (Prothrombin) Inhibitors
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Factor II (Prothrombin) Inhibitors by Therapy Area, 2018
• Number of Products under Development for Factor II (Prothrombin) Inhibitors, 2018
• Number of Products under Development by Companies
• Comparative Analysis by Filed and Phase III Products, 2018
• Comparative Analysis Phase II Products, 2018
• Comparative Analysis Phase I and IND Filed Products, 2018
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2018
• Drug Candidates Profiles
• Factor II (Prothrombin) Inhibitors Assessment by Monotherapy Products
• Factor II (Prothrombin) Inhibitors Assessment by Combination Products
• Factor II (Prothrombin) Inhibitors Assessment by Route of Administration
• Factor II (Prothrombin) Inhibitors Assessment by Stage and Route of Administration
• Factor II (Prothrombin) Inhibitors Assessment by Molecule Type
• Factor II (Prothrombin) Inhibitors Assessment by Stage and Molecule Type
• Factor II (Prothrombin) Inhibitors Therapeutics – Discontinued Products
• Factor II (Prothrombin) Inhibitors Therapeutics – Dormant Products
• Products under Development by Companies, 2018


List of Figures
• Number of Products under Development for Factor II (Prothrombin) Inhibitors by Therapy Area, 2018
• Number of Products under Development for Factor II (Prothrombin) Inhibitors, 2018
• Filed and Phase III Products, 2018
• Phase II Products, 2018
• Phase I and IND Filed Products, 2018
• Discovery and Pre-Clinical Stage Products, 2018
• Factor II (Prothrombin) Inhibitors Assessment by Monotherapy Products
• Factor II (Prothrombin) Inhibitors Assessment by Combination Products
• Factor II (Prothrombin) Inhibitors Assessment by Route of Administration
• Factor II (Prothrombin) Inhibitors Assessment by Stage and Route of Administration
• Factor II (Prothrombin) Inhibitors Assessment by Molecule Type
• Factor II (Prothrombin) Inhibitors Assessment by Stage and Molecule Type


*** レポートのキーワード ***

第Ⅱ因子阻害剤、医薬品、製薬、研究開発、パイプライン、治療、治験

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • プディング・デザート市場動向(~2017):アルゼンチン
    Synopsis The report presents detailed data on consumption trends in the Puddings/Desserts category in Argentina, analyzing consumption volumes and values at segment level. It also provides indispensable data on distribution channels along with latest industry news and mergers & acquisitions (of Dair …
  • 豆乳市場:ラテンアメリカ(市場動向~2019)
    Synopsis Canadean’s, "Soymilk Market in Latin America to 2019: Market Guide" provides a snapshot of the Soymilk consumption in Latin America. The quantitative data in the report provides historic and forecast consumption data of the market by country, giving a simple overview of the Soymilk market t …
  • カナダの血液検査市場
    Canada Haematology Market Outlook to 2021 Summary GlobalData’s new report, "Canada Haematology Market Outlook to 2021", provides key market data on the Canada Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haemato …
  • 世界の油性インク樹脂市場2017
    Notes:Sales, means the sales volume of Oil-based Ink Resin Revenue, means the sales value of Oil-based Ink Resin This report studies sales (consumption) of Oil-based Ink Resin in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, w …
  • モロッコの建築用プラスチック製品市場(~2019):市場規模、動向、予測
    The report Plastic Construction Product Market in Morocco to 2019 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future outlook for plastic construction products in Morocco. The research includes historic data from 2008 to 2014 …
  • 世界及び中国のメタアルデヒド市場2017
    The 'Global and Chinese Metaldehyde Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Metaldehyde industry with a focus on the Chinese market. The report provides key statistics on the market status of the Metaldehyde manufacturers an …
  • エポキシ樹脂の世界市場:インサイト、市場機会、市場シェア、市場予測
    The global epoxy resins market is estimated to reach $12.15 billion by 2022 and is expected to grow at CAGR of 9.6% during 2016-2022. The Epoxy resins market is segmented on the basis of application and geography. The application segment is further segmented into adhesives, composites, construction, …
  • 市場動向と機会分析レポート:Gambian個人障害保険及び健康保険産業
    “Trends and Opportunities in the Gambian Personal Accident and Health Insurance Industry to 2017: Market Profile” is the result of extensive research into the insurance industry, covering the personal accident and health insurance market in Gambia. The report provides data on key industry trends, ma …
  • 下垂体機能低下症(Hypopituitarism):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)
    SUMMARY DelveInsight’s Report, “Hypopituitarism-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hypopituitarism …
  • Dana Gas PJSCの企業概要及び財務/SWOT分析
    Dana Gas PJSC Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Dana Gas PJSC annual and quarterly forecasts made by stock market experts. The report also enables direct compar …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIMR2016267 )"第Ⅱ因子阻害剤のパイプライン・インサイト2018" (英文:Factor II (Prothrombin) Inhibitors -Pipeline Insights, 2018)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。